Cystic Fibrosis Foundation invests $13m in SpliSense
The investment comes following positive results in an initial efficacy trial, Phase IIa, in which an improvement in lung function ...
The investment comes following positive results in an initial efficacy trial, Phase IIa, in which an improvement in lung function ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.